NEW YORK (GenomeWeb) – D-Mark Biosciences will distribute Sygnis' TruePrime Single Cell WGA kit in Canada as part of a non-exclusive deal that Sygnis announced today.

D-Mark will promote, market, and sell the kit, which eliminates the need for synthetic random primers in whole-genome amplification. The kit is based on the recently discovered DNA primase TthPrimPol and the Phi29 polymerase and is the first of a number of anticipated products under the TruePrime name, Sygnis said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.